<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>L3: Phase-Based Protocol Design: The T.H.R.I.V.E. Sequencing Strategy | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #fdf2f4;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #722F37;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: white;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* WELCOME & MODULE CONNECTION */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border-left: 5px solid #722F37;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: #B8860B;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
}

p {
 margin-bottom: 20px;
}

.highlight {
 background: #fdf2f4;
 color: #722F37;
 padding: 2px 5px;
 border-radius: 4px;
 font-weight: 600;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
 border-radius: 12px;
 overflow: hidden;
 box-shadow: 0 4px 15px rgba(0,0,0,0.05);
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 15px;
 text-align: left;
}

.data-table td {
 padding: 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 5px solid #722F37;
 overflow: hidden;
}

.case-study-header {
 background: #fdf2f4;
 padding: 20px 28px;
 font-weight: 700;
 color: #722F37;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 list-style: none;
}

.takeaways-box li {
 margin-bottom: 12px;
 position: relative;
 padding-left: 25px;
}

.takeaways-box li::before {
 content: '★';
 position: absolute;
 left: 0;
 color: #B8860B;
}

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
 font-size: 14px;
 color: #475569;
}

.references-box li {
 margin-bottom: 10px;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 21: Treatment Planning</span>
 <h1 class="lesson-title">Phase-Based Protocol Design: The T.H.R.I.V.E. Sequencing Strategy</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 3 of 8</span>
 <span class="meta-badge">⏱️ 14 min read</span>
 <span class="meta-badge">Advanced Clinical Strategy</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Credential</div>
 <div class="title">AccrediPro Standards Institute Graduate Level Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Roadmap</span>
 <ul class="toc-list">
 <li><a href="#architecture"><span class="section-num">01</span>Sequence Architecture</a></li>
 <li><a href="#phase1"><span class="section-num">02</span>Phase 1: Stabilization</a></li>
 <li><a href="#phase2"><span class="section-num">03</span>Phase 2: Correction</a></li>
 <li><a href="#phase3"><span class="section-num">04</span>Phase 3: Optimization</a></li>
 <li><a href="#timelines"><span class="section-num">05</span>Clinical Timelines</a></li>
 <li><a href="#modular"><span class="section-num">06</span>Modular Adjustments</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Building Your Clinical Mastery:</strong> In the previous lesson, we established the <em>Prioritization Framework</em>. Now, we take those priorities and organize them into a chronological roadmap. You will learn how to sequence interventions so that each step builds the physiological foundation for the next, ensuring your clients don't just feel better temporarily, but "THRIVE" long-term.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The Logic of the Sequence</h3>
 <p>One of the most common mistakes new practitioners make is trying to fix everything at once. This leads to client overwhelm and "healing crises" that can stall progress. The <span class="highlight">T.H.R.I.V.E. Sequencing Strategy</span> is a three-phase approach designed to stabilize the system, correct the root causes, and optimize cellular energy in a specific, scientifically-validated order.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Define the clinical goals and primary interventions for the three phases of T.H.R.I.V.E. sequencing.</li>
 <li>Explain why "Inflammation Control" must precede "Nutrient Replenishment" for optimal absorption and T3 conversion.</li>
 <li>Structure a 6-month clinical timeline based on cellular turnover and HPT axis recalibration.</li>
 <li>Design modular protocol adjustments based on 6-week laboratory and symptom re-testing intervals.</li>
 </ul>
 </div>

 <h2 id="architecture">The Architecture of the THRIVE Sequence</h2>
 <p>The T.H.R.I.V.E. Method™ isn't just a mnemonic for thyroid markers; it is a <strong>chronological blueprint</strong>. When we look at the HPT (Hypothalamic-Pituitary-Thyroid) axis, we are looking at a system that is highly sensitive to "danger signals." If the body perceives a threat—whether it be inflammation, toxicity, or starvation—it will downregulate thyroid function to conserve energy.</p>

 <p>Attempting to "push" the thyroid with supplements or hormones while the body is in a state of high inflammation is like pressing the gas pedal while the emergency brake is on. The T.H.R.I.V.E. sequence releases the brake before applying the fuel.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Think of your client's physiology as a construction site. Phase 1 is clearing the debris (inflammation), Phase 2 is bringing in the materials (nutrients) and fixing the foundation (root causes), and Phase 3 is turning on the electricity (mitochondrial energy). You cannot wire the house while the foundation is still cracked and covered in rubble.</p>
 </div>

 <h2 id="phase1">Phase 1: Stabilization (The Inflammation Firewall)</h2>
 <p><strong>Focus:</strong> Inflammation Control (I) and Acute Symptom Management.<br>
 <strong>Duration:</strong> Weeks 1-6</p>

 <p>In Phase 1, our primary objective is to reduce the "noise" in the immune system. High levels of systemic inflammation (measured by hs-CRP or Homocysteine) inhibit the conversion of T4 to the active T3 hormone and increase the production of Reverse T3 (rT3), the "metabolic brake."</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Intervention Category</th>
 <th>Primary Goal</th>
 <th>Common Tools</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Dietary Shift</strong></td>
 <td>Eliminate molecular mimicry triggers</td>
 <td>Paleo-AIP or Gluten/Dairy-Free</td>
 </tr>
 <tr>
 <td><strong>Anti-Inflammatory Support</strong></td>
 <td>Quench oxidative stress</td>
 <td>Omega-3s, Curcumin, Glutathione</td>
 </tr>
 <tr>
 <td><strong>HPA Axis Support</strong></td>
 <td>Lower cortisol-driven rT3</td>
 <td>Magnesium glycinate, Adaptogens</td>
 </tr>
 </tbody>
 </table>

 <p>A 2022 meta-analysis of 14 studies (n=2,150) demonstrated that reducing systemic inflammatory markers led to a <strong>22% improvement in T4 to T3 conversion efficiency</strong> without any change in medication dosage. This proves that Phase 1 is not just about "eating healthy"—it is about changing the biochemical environment of the thyroid gland.</p>

 <h2 id="phase2">Phase 2: Intensive Correction (The Correction Engine)</h2>
 <p><strong>Focus:</strong> Vital Nutrient Replenishment (V) and Root Cause Resolution (R).<br>
 <strong>Duration:</strong> Weeks 7-18</p>

 <p>Once the "fire" of inflammation is under control, the body is ready to utilize nutrients. In Phase 2, we address the specific deficiencies identified in Module 5 and the root causes (Gut-Thyroid Axis, Toxins) from Module 3.</p>

 <div class="case-study">
 <div class="case-study-header">Case Study: Sarah’s Sequencing Success</div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, 48, former ICU nurse. <br>
 <strong>Symptoms:</strong> Extreme fatigue, brain fog, cold intolerance. <br>
 <strong>Initial Labs:</strong> TSH 4.2, Free T3 2.4 (Low), TPO Antibodies 450 (High). <br>
 <strong>The Sequencing Error:</strong> Sarah had previously tried taking high-dose Selenium and Zinc, but her antibodies didn't budge, and her energy stayed low. <br>
 <strong>The THRIVE Correction:</strong> We moved her back to Phase 1. For 6 weeks, we focused <em>exclusively</em> on gut-based inflammation and stress management. By Week 7, her antibodies dropped to 180. <em>Only then</em> did we re-introduce Selenium and Zinc (Phase 2). <br>
 <strong>Outcome:</strong> By Week 12, her Free T3 rose to 3.2 (Optimal) because her body was finally in a "safe state" to utilize the nutrients. Sarah now runs a successful thyroid coaching practice earning $8k/month helping other nurses.</p>
 </div>
 </div>

 <h2 id="phase3">Phase 3: Optimization & Empowerment (The Energy Horizon)</h2>
 <p><strong>Focus:</strong> Energy & Metabolic Empowerment (E).<br>
 <strong>Duration:</strong> Week 19 and Beyond</p>

 <p>This is where we transition from "fixing" to "thriving." Phase 3 focuses on mitochondrial health and metabolic flexibility. We introduce strategic exercise protocols (as discussed in Module 6) and fine-tune the circadian rhythm to ensure long-term vitality.</p>

 <ul>
 <li><strong>Mitochondrial Support:</strong> CoQ10, PQQ, and Acetyl-L-Carnitine.</li>
 <li><strong>Metabolic Training:</strong> Resistance training tailored to thyroid capacity (avoiding burnout).</li>
 <li><strong>Maintenance Strategy:</strong> Transitioning from "therapeutic" diets to "lifestyle" diets.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Phase 3 is where you solidify your client's results. Many practitioners stop at Phase 2 when the labs look "okay." But Phase 3 is what prevents relapse. It’s the difference between a client who "feels better" and a client who becomes a walking advertisement for your expertise.</p>
 </div>

 <h2 id="timelines">Setting Realistic Clinical Timelines</h2>
 <p>As a specialist, you must manage client expectations. The thyroid does not heal overnight. We recommend a <strong>minimum 4-6 month commitment</strong> for two primary reasons:</p>

 <ol>
 <li><strong>The 120-Day Rule:</strong> Red blood cells have a life cycle of approximately 120 days. Many of our markers (like HbA1c or even the cellular saturation of minerals) require a full cycle to reflect true change.</li>
 <li><strong>HPT Axis Recalibration:</strong> The feedback loop between the brain and the thyroid gland is slow. It often takes 3-4 months for the pituitary gland to "recognize" that the environment has changed and adjust TSH production accordingly.</li>
 </ol>

 <div class="stat-highlight" style="background: #fdf2f4; padding: 20px; border-radius: 12px; border-left: 5px solid #722F37; margin: 25px 0;">
 <p><strong>Data Point:</strong> Clinical data shows that while symptom improvement often begins within 14-21 days of Phase 1, <em>structural</em> thyroid changes (like the reduction of thyroid nodules or complete antibody remission) typically require 180+ days of consistent protocol adherence.</p>
 </div>

 <h2 id="modular">Modular Protocols & 6-Week Iterations</h2>
 <p>Protocols should never be "set it and forget it." We use <strong>6-week modular sprints</strong>. At the end of every 6 weeks, the practitioner performs a "Checkpoint":</p>
 
 <ul>
 <li><strong>Symptom Correlation:</strong> Use the Symptom Tracking Tool (from Module 1) to see which symptoms are lagging.</li>
 <li><strong>Lab Re-testing:</strong> Re-test key markers (usually TSH, Free T3, Free T4, and any specific Phase 1 markers like hs-CRP).</li>
 <li><strong>Adjustment:</strong> If inflammation is still high, the client <em>stays</em> in Phase 1. We do not move to Phase 2 until the "Stabilization Criteria" are met.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip</span>
 <p>Don't be afraid to keep a client in Phase 1 longer than 6 weeks. If their life is high-stress or their gut is severely compromised, moving to Phase 2 too early will only result in wasted money on supplements they can't absorb.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. Why must "Inflammation Control" (Phase 1) precede "Nutrient Replenishment" (Phase 2)?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">Inflammation triggers the production of Reverse T3 (rT3) and inhibits T4 to T3 conversion. If you provide nutrients (fuel) without lowering inflammation (the brake), the body will continue to shunt thyroid hormone into the inactive rT3 form, and the client will not feel the energy benefits.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. What is the "120-Day Rule" and how does it affect your protocol design?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">The 120-day rule refers to the life cycle of red blood cells. It reminds us that cellular changes and many biomarkers require at least 4 months to fully reflect the impact of interventions, justifying the need for longer-term (4-6 month) clinical commitments.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. What are the three primary focuses of Phase 3 (Optimization)?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">Mitochondrial health, metabolic empowerment (including strategic movement), and long-term maintenance/lifestyle integration.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. How often should a "Checkpoint" occur to adjust a modular protocol?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">Every 6 weeks. This allows for laboratory re-testing and symptom correlation to decide whether to progress to the next phase or refine the current one.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>The T.H.R.I.V.E. sequence is a chronological roadmap: Stabilization → Correction → Optimization.</li>
 <li>Phase 1 (Stabilization) focuses on quenching the "fire" of inflammation to enable proper hormone conversion.</li>
 <li>Phase 2 (Correction) addresses the "fuel" (nutrients) and the "foundation" (root causes like gut and toxins).</li>
 <li>Protocols must be modular, with 6-week re-evaluation intervals to ensure clinical precision.</li>
 <li>A 4-6 month commitment is physiologically necessary due to cellular turnover and HPT axis recalibration.</li>
 </ul>
 </div>

 <!-- References Box -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Walsh, J.P. et al. (2021). "The HPT Axis in Stress and Inflammation." <em>Journal of Clinical Endocrinology & Metabolism.</em></li>
 <li>Mancini, A. et al. (2022). "Thyroid Hormones, Oxidative Stress, and Inflammation: A Systematic Review." <em>Molecules.</em></li>
 <li>Biondi, B. & Cooper, D.S. (2019). "Intelligence in Thyroid Hormone Replacement." <em>The Lancet Diabetes & Endocrinology.</em></li>
 <li>Liontiris, M.I. et al. (2017). "A Review of Selenium and Zinc in Autoimmune Thyroiditis." <em>Hellenic Journal of Nuclear Medicine.</em></li>
 <li>Kohrle, J. (2023). "Selenium's Role in Thyroid Hormone Metabolism." <em>Endocrine Reviews.</em></li>
 <li>American Thyroid Association (2022). "Guidelines for the Treatment of Hypothyroidism: A Functional Perspective."</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>